Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Clinical trial NCT02029950 · COMPLETED
Trial details
- NCT number
- NCT02029950
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-16
- Primary completion
- 2020-05-13
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.